Changes in the composition of the extracellular matrix in patellar tendinopathy

Matrix Biology

Volumn 28, Issue 4, 2009, Pages 230-236

  Tom, Samiric ^a   Parkinson, John ^a   Ilic, Mirna Z ^a   Cook, Jill ^b   Feller, Julian A ^a   Handley, Christopher J ^a  

^a LA TROBE UNIVERSITY   (Australia)

^b DEAKIN UNIVERSITY   (Australia)

Author keywords

Collagen; Patellar tendinopathy; Proteoglycans; Tendon

Indexed keywords

AGGRECAN; BIGLYCAN; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; DECORIN; FIBROMODULIN; GLYCOSAMINOGLYCAN; PROTEOGLYCAN; VERSICAN;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PATELLA TENDON; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; TENDINITIS; UPREGULATION;

ADOLESCENT; ADULT; ATHLETIC INJURIES; BODY WATER; CUMULATIVE TRAUMA DISORDERS; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GLYCOSAMINOGLYCANS; HUMANS; HYDROXYPROLINE; MALE; MIDDLE AGED; PATELLAR LIGAMENT; POLYMERASE CHAIN REACTION; PROTEOGLYCANS; RNA, MESSENGER; TENDINOPATHY; YOUNG ADULT;

EID: 67349241969     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.matbio.2009.04.001     Document Type: Article

References (42)

1. Alfredson H., and Lorentzon R. Chronic Achilles tendinosis: recommendations for treatment and prevention. Sports Med. (Auckland, NZ). 29 (2000) 135-146
2. Alfredson H., Lorentzon M., Backman S., Backman A., and Lerner U.H. cDNA-arrays and real-time quantitative PCR techniques in the investigation of chronic Achilles tendinosis. J. Orthop. Res. 21 (2003) 970-975
3. Astrom M., and Rausing A. Chronic Achilles tendinopathy. A survey of surgical and histopathologic findings. Clin. Orthop. Relat. Res. 316 (1995) 151-164
4. Bank R.A., TeKoppele J.M., Oostingh G., Hazleman B.L., and Riley G.P. Lysylhydroxylation and non-reducible crosslinking of human supraspinatus tendon collagen: changes with age and in chronic rotator cuff tendinitis. Ann. Rheum. Dis. 58 (1999) 35-41
5. Benjamin M., and Ralphs J.R. Tendons and ligaments-an overview. Histol. Histopathol. 12 (1997) 1135-1144
6. Berenson M.C., Blevins F.T., Plaas A.H., and Vogel K.G. Proteoglycans of human rotator cuff tendons. J. Orthop. Res. 14 (1996) 518-525
7. Birch H.L. Tendon matrix composition and turnover in relation to functional requirements. Int. J. Exp. Pathol. 88 (2007) 241-248
8. Caterson B., Christner J.E., and Baker J.R. Identification of a monoclonal antibody that specifically recognizes corneal and skeletal keratan sulfate. Monoclonal antibodies to cartilage proteoglycan. J. Biol. Chem. 258 (1983) 8848-8854
9. Caterson B., Christner J.E., Baker J.R., and Couchman J.R. Production and characterization of monoclonal antibodies directed against connective tissue proteoglycans. Fed. Proc. 44 (1985) 386-393
10. Chard M.D., Cawston T.E., Riley G.P., Gresham G.A., and Hazleman B.L. Rotator cuff degeneration and lateral epicondylitis: a comparative histological study. Ann. Rheum. Dis. 53 (1994) 30-34
11. Cook J.L., Khan K.M., Harcourt P.R., Grant M., Young D.A., and Bonar S.F. A cross sectional study of 100 athletes with jumper's knee managed conservatively and surgically. The Victorian Institute of Sport Tendon Study Group. Br. J. Sports Med. 31 (1997) 332-336
12. Cook J.L., Khan K.M., and Purdam C. Achilles tendinopathy. Man. Ther. 7 (2002) 121-130
13. Corps A.N., Robinson A.H., Movin T., Costa M.L., Ireland D.C., Hazleman B.L., et al. Versican splice variant messenger RNA expression in normal human Achilles tendon and tendinopathies. Rheumatology (Oxford) 43 (2004) 969-972
14. Corps A.N., Robinson A.H., Movin T., Costa M.L., Hazleman B.L., and Riley G.P. Increased expression of aggrecan and biglycan mRNA in Achilles tendinopathy. Rheumatology (Oxford) 45 (2006) 291-294
15. Corps A.N., Jones G.C., Harrall R.L., Curry V.A., Hazleman B.L., and Riley G.P. The regulation of aggrecanase ADAMTS-4 expression in human Achilles tendon and tendon-derived cells. Matrix Biol. 27 (2008) 393-401
16. de Mos M., van El B., DeGroot J., Jahr H., van Schie H.T., van Arkel E.R., et al. Achilles tendinosis: changes in biochemical composition and collagen turnover rate. Am. J. Sports Med. 35 (2007) 1549-1556
17. Dours-Zimmermann M.T., and Zimmermann D.R. A novel glycosaminoglycan attachment domain identified in two alternative splice variants of human versican. J. Biol. Chem. 269 (1994) 32992-32998
18. Farndale R.W., Buttle D.J., and Barrett A.J. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim. Biophys. Acta 883 (1986) 173-177
19. Fisher L.W., Termine J.D., and Young M.F. Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. J. Biol. Chem. 264 (1989) 4571-4576
20. Fisher L.W., Stubbs III J.T., and Young M.F. Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins. Acta Orthop. Scand., Suppl. 266 (1995) 61-65
21. Fu S.C., Chan B.P., Wang W., Pau H.M., Chan K.M., and Rolf C.G. Increased expression of matrix metalloproteinase 1 (MMP1) in 11 patients with patellar tendinosis. Acta Orthop. Scand. 73 (2002) 658-662
22. Fu S.C., Chan K.M., and Rolf C.G. Increased deposition of sulfated glycosaminoglycans in human patellar tendinopathy. Clin. J. Sport Med. 17 (2007) 129-134
23. Ireland D., Harrall R., Curry V., Holloway G., Hackney R., Hazleman B., et al. Multiple changes in gene expression in chronic human Achilles tendinopathy. Matrix Biol. 20 (2001) 159-169
24. Jarvinen M., Jozsa L., Kannus P., Jarvinen T.L., Kvist M., and Leadbetter W. Histopathological findings in chronic tendon disorders. Scand. J. Med. Sci. Sports 7 (1997) 86-95
25. Jones G.C., Corps A.N., Pennington C.J., Clark I.M., Edwards D.R., Bradley M.M., et al. Expression profiling of metalloproteinases and tissue inhibitors of metalloproteinases in normal and degenerate human Achilles tendon. Arthritis Rheum. 54 (2006) 832-842
26. Kannus P. Etiology and pathophysiology of chronic tendon disorders in sports. Scand. J. Med. Sci. Sports 7 (1997) 78-85
27. Khan K.M., Bonar F., Desmond P.M., Cook J.L., Young D.A., Visentini P.J., et al. Patellar tendinosis (jumper's knee): findings at histopathologic examination, US, and MR imaging. Victorian Institute of Sport Tendon Study Group. Radiology 200 (1996) 821-827
28. Kinsella M.G., Bressler S.L., and Wight T.N. The regulated synthesis of versican, decorin, and biglycan: extracellular matrix proteoglycans that influence cellular phenotype. Crit. Rev. Eukaryot. Gene Expr. 14 (2004) 203-234
29. Maffulli N., Ewen S.W., Waterston S.W., Reaper J., and Barrass V. Tenocytes from ruptured and tendinopathic Achilles tendons produce greater quantities of type III collagen than tenocytes from normal Achilles tendons. An in vitro model of human tendon healing. Am. J. Sports Med. 28 (2000) 499-505
30. O'Brien M. Structure and metabolism of tendons. Scand. J. Med. Sci. Sports 7 (1997) 55-61
31. Oegema Jr. T.R., Hascall V.C., and Eisenstein R. Characterization of bovine aorta proteoglycan extracted with guanidine hydrochloride in the presence of protease inhibitors. J. Biol. Chem. 254 (1979) 1312-1318
32. Riley G. The pathogenesis of tendinopathy. A molecular perspective. Rheumatology (Oxford) 43 (2004) 131-142
33. Riley G.P., Harrall R.L., Constant C.R., Chard M.D., Cawston T.E., and Hazleman B.L. Glycosaminoglycans of human rotator cuff tendons: changes with age and in chronic rotator cuff tendinitis. Ann. Rheum. Dis. 53 (1994) 367-376
34. Riley G.P., Harrall R.L., Constant C.R., Chard M.D., Cawston T.E., and Hazleman B.L. Tendon degeneration and chronic shoulder pain: changes in the collagen composition of the human rotator cuff tendons in rotator cuff tendinitis. Ann. Rheum. Dis. 53 (1994) 359-366
35. Riley G.P., Goddard M.J., and Hazleman B.L. Histopathological assessment and pathological significance of matrix degeneration in supraspinatus tendons. Rheumatology (Oxford) 40 (2001) 229-230
36. Riley G.P., Curry V., DeGroot J., van El B., Verzijl N., Hazleman B.L., et al. Matrix metalloproteinase activities and their relationship with collagen remodelling in tendon pathology. Matrix Biol. 21 (2002) 185-195
37. Samiric T., Ilic M.Z., and Handley C.J. Characterisation of proteoglycans and their catabolic products in tendon and explant cultures of tendon. Matrix Biol. 23 (2004) 127-140
38. Schaefer L., and Iozzo R.V. Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction. J. Biol. Chem. 283 (2008) 21305-21309
39. Scott A., Lian O., Roberts C.R., Cook J.L., Handley C.J., Bahr R., et al. Increased versican content is associated with tendinosis pathology in the patellar tendon of athletes with jumper's knee. Scand. J. Med. Sci. Sports 18 (2008) 427-435
40. Sharma P., and Maffulli N. Biology of tendon injury: healing, modeling and remodeling. J. Musculoskelet. Neuronal Interact. 6 (2006) 181-190
41. Sobue M., Nakashima N., Fukatsu T., Nagasaka T., Fukata S., Ohiwa N., et al. Production and immunohistochemical characterization of a monoclonal antibody raised to proteoglycan purified from a human yolk sac tumour. Histochem. J. 21 (1989) 455-460
42. Stegemann H., and Stalder K. Determination of hydroxyproline. Clin. Chim. Acta 18 (1967) 267-273